- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01801579
Reproducibility of Ankle Brachial Index After Maximal Exercise (RICATEM)
February 11, 2016 updated by: University Hospital, Angers
Reproducibility of the Ankle-Brachial Index Measurements After a Maximal Exercise
Hemodynamic changes in the lower limbs are very important and rapid after maximal exercise.
The automatic method allows a fastest measurement of the Ankle-Brachial Index (ABI).
Thus, it appears important to know whether automatic assessment of ABI is as reliable and reproducible as the manual method.
Study Overview
Status
Completed
Conditions
Detailed Description
Two methods are mainly used to determine the blood pressure at rest, in a non-invasive way, in order to calculate the Ankle-Brachial Index (ABI).
The first method, using a manual sphygmomanometer coupled with a Doppler probe, is considered as the reference method.
The second method requires at least one automatic sphygmomanometer.
Data from the literature show that these two methods are reproducible to assess ABI at rest.
Some authors have reported a better reproducibility of measurements with automatic tool.
Others consider that the current accuracy of automatic measurement is insufficient to replace the reference method Doppler.
Thus, the aime of the present study is to evaluate whether automatic assessment of ABI is as reliable and reproducible as the manual method.
Study Type
Observational
Enrollment (Actual)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Angers, France, 49933
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
health volunteers over 18 years old
Description
Inclusion Criteria:
- Participant between 18 and 40 years old
- Informed consent signed
- Exclusion Criteria:
- Do not want to participate to the protocol
- Pregnant woman
- Adults to enhanced protection, deprived of their liberty by judicial or administrative authority, without consent hospitalized or admitted to a health facility or social purposes other than research
- Being in a period of exclusion from another biomedical study
- Amputee or with a member dysgenesis
- Not allowed to perform a maximal exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Test-retest difference in ankle to brachial pressure index
Time Frame: up to 2 week
|
Comparison of differendces observed on test-retest measures with manual and automatic measurements
|
up to 2 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of recordings.
Time Frame: up to 2 weeks
|
Comaprison of the time needed to complete the recording with automatic vs. manual techniques
|
up to 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Antoine BRUNEAU, MD, University Hospital, Angers
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
February 18, 2013
First Submitted That Met QC Criteria
February 26, 2013
First Posted (Estimate)
March 1, 2013
Study Record Updates
Last Update Posted (Estimate)
February 12, 2016
Last Update Submitted That Met QC Criteria
February 11, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2012-A01036-37
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Subjects
-
Temple UniversityCompleted
-
University of California, DavisCompletedNormal SubjectsUnited States
-
Universidade Federal de PernambucoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsCompleted
-
Madigan Army Medical CenterUnknownNormal SubjectsUnited States
-
Halia Therapeutics, Inc.TKL Research, Inc.Completed
-
Tetraphase Pharmaceuticals, Inc.Completed
-
Yonsei UniversityUnknownNormal Healthy SubjectsKorea, Republic of
-
Yonsei UniversityCompletedNormal Healthy SubjectsKorea, Republic of
-
Schiefer UlrichCompletedOphthalmologically Normal SubjectsGermany
-
Taiwan Liposome CompanyCompleted